Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Resveratrol (trans‐3,4′,5‐trihydroxystilbene) is a naturally occurring polyphenolic phytoalexin found in grapes, and has been shown to inhibit the growth of various types of cancer cells. We investigated the mechanism of the antiproliferative effect of resveratrol in A431‐transformed keratinocytes harbouring mutant p53, and show that it is accompanied by G1 cell cycle arrest, which coincides with a marked inhibition of G1 cell cycle regulatory proteins, including cyclins A and D1 and cyclin‐dependent kinase (CDK)6 and p53‐independent induction of p21WAF1. Cell cycle arrest was also associated with the accumulation of hypophosphorylated Rb and p27KIP1. Resveratrol inhibited mitogen‐activated protein kinase/extracellular signal‐regulated kinase kinase (MEK)1 > extracellular signal‐regulated protein kinase (ERK)1/2 signalling, downregulated c‐Jun, and suppressed activating protein (AP)‐1 DNA‐binding and promoter activity. In addition, the inhibition of MEK1 > ERK1/2 signalling appears to be independent of retinoblastoma protein (pRb) hypophosphorylation in A431 cells, as PD098059 did not suppress pRb phosphorylation. Our results demonstrate that resveratrol affects multiple cellular targets in A431 cells, and that the downregulation of both AP‐1 and pRb contributes to its antiproliferative activity in these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kapadia, G. J., Azuine, M. A., Tokuda, H., Takasaki, M., Mukainaka, T., Konoshima, T., & Nishino, H. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0992 · Cited by 238
Research works printed but not linked: 38
- 10.1358/dnp.2003.16.5.829318 · DOI · Paper page
- 10.1016/0009-8981(96)06236-5 · DOI · Paper page
- 10.1016/S0024-3205(97)00883-7 · DOI · Paper page
- 10.1016/S0006-2952(98)00350-5 · DOI
- Aggarwal B B, 2004, Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res, 24, 2783
- Jang M, 1999, Cancer chemopreventive activity of resveratrol, Drugs Exp Clin Res, 25, 65
- 10.2741/afaq · DOI · Paper page
- 10.1159/000064533 · DOI · Paper page
- 10.1096/fj.04-3582fje · DOI · Paper page
- Marks R, 1995, Skin cancer, Recogn Treat Drugs, 50, 48
- 10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N · doi:10.1002/1096-9896(2000)9999:9999<::aid-path815>3.0.co;2-n
- 10.1562/0031-8655(2002)0750058SSAOCE2.0.CO2 · DOI
- 10.1046/j.1523-1747.2002.01734.x · DOI
- 10.1016/0092-8674(90)90395-U · DOI · Paper page
- 10.1101/gad.13.5.607 · DOI · Paper page
- 10.1182/blood.V79.8.2107.bloodjournal7982107 · DOI
- 10.1016/S0092-8674(00)00193-8 · DOI · Paper page
- 10.1073/pnas.96.17.9827 · DOI · Paper page
- 10.1038/sj.onc.1203603 · DOI · Paper page
- 10.1128/MCB.23.13.4494-4510.2003 · DOI · Paper page
- 10.1093/carcin/19.5.765 · DOI
- 10.1093/carcin/20.2.193 · DOI
- 10.1091/mbc.8.2.287 · DOI · Paper page
- 10.1073/pnas.92.17.7686 · DOI · Paper page
- 10.1074/jbc.273.29.18623 · DOI · Paper page
- 10.1016/S0165-6147(00)01865-4 · DOI · Paper page
- 10.1016/S0955-0674(97)80068-3 · DOI · Paper page
- 10.1074/jbc.M306614200 · DOI · Paper page
- 10.1007/0-306-48158-8_9 · DOI · Paper page
- Suyama H, 2004, ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells, Int J Oncol, 24, 1499
- 10.1111/j.0906-6705.2005.00317.x · DOI
- 10.1124/mol.104.006023 · DOI
- 10.1128/MCB.11.9.4466 · DOI · Paper page
- 10.1128/MCB.11.5.2451 · DOI · Paper page
- 10.1002/jcb.240550410 · DOI
- Herber B, 1994, Inducible regulatory elements in the human cyclin D1 promoter, Oncogene, 9, 2105
- 10.1074/jbc.274.48.34186 · DOI · Paper page
- 10.1128/MCB.18.9.5609 · DOI · Paper page
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Resveratrol: A review of preclinical studies for human cancer prevention
ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731
Self-citationAnti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
Polyphenolic phytochemicals – just antioxidants or much more?
Stevenson, D. E., & Hurst, R. D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7237-1 · Cited by 550
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Kundu, J. K., & Surh, Y.-J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 473
Metadata
- Authors
- Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M.
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2006-06-02
- Volume
- 15
- Issue
- 7
- Pages
- 538-546
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2161809170
- Cited by
- 98
- References
- 1
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways. https://app.cochat.ai/papers/10.1111/j.1600-0625.2006.00445.x
- The paper
- Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M. (2006). Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways. Experimental Dermatology. https://doi.org/10.1111/j.1600-0625.2006.00445.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.